Delivery Order SPE2DB22D3102-SPE2DB24FK8TU
Award Date 10/27/23
Potential Completion Date 10/30/23
Potential Value $9.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the supply of pharmaceutical products, including the HIV medication Biktarvy, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,942.86 and an ultimate completion date of December 12, 2023. It is a delivery order contract with a firm fixed-price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
- This federal contract award is for the delivery of pharmaceutical products, including the HIV medication Biktarvy, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order valued at $25,126.56, with an ultimate completion date of March 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,815.46 firm-fixed-price delivery order contract is for the supply of the HIV medication Biktarvy, with a period of performance through May 14, 2025. The contract is not set aside and was awarded as part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,919.26, is for the supply of the HIV medication Biktarvy. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
- This federal contract award, valued at $19,773.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of the prescription medication Biktarvy, a treatment for human immunodeficiency virus (HIV). The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. Additionally, AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $29,664.17 firm-fixed-price delivery order is for the supply of the HIV medication Biktarvy. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,625.39, is a Firm Fixed Price Delivery Order for the provision of the drug Biktarvy, a medication used to treat HIV. The contract has an ultimate completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the HIV medication Biktarvy in 30-count tablet packages. The contract, valued at $17,907.06, was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a significant...
- This federal contract award is for the delivery of pharmaceutical products, including the anti-HIV medication Biktarvy, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also a registered federal contractor. The contract, valued at $105,858.88, is a firm-fixed-price delivery order that was...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,515.47 delivery order contract is for the supply of Biktarvy, a brand-name HIV medication, with a performance period ending on August 1, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...